- Home
- ASRT vs ARMP Comparison
ASRT vs ARMP Comparison
Compare ASRT & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ARMP
- Stock Information
- Founded
- ASRT 1995
- ARMP N/A
- Country
- ASRT United States
- ARMP United States
- Employees
- ASRT N/A
- ARMP N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASRT Health Care
- ARMP Health Care
- Exchange
- ASRT Nasdaq
- ARMP Nasdaq
- Market Cap
- ASRT 57.9M
- ARMP 52.1M
- IPO Year
- ASRT 1997
- ARMP N/A
- Fundamental
- Price
- ASRT $0.65
- ARMP $1.91
- Analyst Decision
- ASRT Strong Buy
- ARMP Strong Buy
- Analyst Count
- ASRT 2
- ARMP 1
- Target Price
- ASRT $3.25
- ARMP $9.00
- AVG Volume (30 Days)
- ASRT 207.4K
- ARMP 36.4K
- Earning Date
- ASRT 08-06-2025
- ARMP 08-12-2025
- Dividend Yield
- ASRT N/A
- ARMP N/A
- EPS Growth
- ASRT N/A
- ARMP N/A
- EPS
- ASRT N/A
- ARMP N/A
- Revenue
- ASRT $119,001,000.00
- ARMP $4,699,000.00
- Revenue This Year
- ASRT N/A
- ARMP $8.43
- Revenue Next Year
- ASRT $11.91
- ARMP N/A
- P/E Ratio
- ASRT N/A
- ARMP N/A
- Revenue Growth
- ASRT N/A
- ARMP 14.24
- 52 Week Low
- ASRT $0.51
- ARMP $0.90
- 52 Week High
- ASRT $1.80
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- ASRT 49.30
- ARMP 52.83
- Support Level
- ASRT $0.60
- ARMP $1.74
- Resistance Level
- ASRT $0.68
- ARMP $2.00
- Average True Range (ATR)
- ASRT 0.03
- ARMP 0.15
- MACD
- ASRT -0.00
- ARMP -0.03
- Stochastic Oscillator
- ASRT 67.00
- ARMP 43.59
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.